Related Experiment Video
Updated: Aug 8, 2026

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
Published on: June 15, 2016
Signal transducer and activator of transcription proteins in leukemias
Mustafa Benekli1, Maria R Baer, Heinz Baumann
1Leukemia Section, Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.
Abstract:
Signal transducer and activator of transcription (STAT) proteins are a 7-member family of cytoplasmic transcription factors that contribute to signal transduction by cytokines, hormones, and growth factors. STAT proteins control fundamental cellular processes, including survival, proliferation, and differentiation. Given the critical roles of STAT proteins, it was hypothesized that inappropriate or aberrant activation of STATs might contribute to cellular transformation and, in particular, leukemogenesis. Constitutive activation of mutated STAT3 has in fact been demonstrated to result in transformation. STAT activation has been extensively studied in leukemias, and mechanisms of STAT activation and the potential role of STAT signaling in leukemogenesis are the focus of this review. A better understanding of mechanisms of dysregulation of STAT signaling pathways may serve as a basis for designing novel therapeutic strategies that target these pathways in leukemia cells.
Insights
Signal transducer and activator of transcription (STAT) proteins regulate cell functions. Aberrant STAT activation, particularly STAT3, is linked to leukemia development, offering potential therapeutic targets.
Area of Science:
- Molecular Biology
- Cellular Biology
- Oncology
Background:
- Signal transducer and activator of transcription (STAT) proteins are key cytoplasmic transcription factors mediating cellular responses to external signals.
- STAT proteins regulate critical cellular processes such as survival, proliferation, and differentiation.
- Dysregulation of STAT signaling is implicated in cellular transformation and diseases like leukemia.
Purpose of the Study:
- To review the mechanisms of STAT activation in leukemias.
- To explore the role of STAT signaling in leukemogenesis.
- To identify potential therapeutic strategies targeting STAT pathways in leukemia.
Main Methods:
- Literature review of STAT protein function and activation in leukemia.
- Analysis of studies investigating STAT signaling pathways in leukemic cells.
- Examination of the link between STAT mutations and cellular transformation.
Main Results:
- Constitutive activation of mutated STAT3 has been shown to cause cellular transformation.
- STAT activation is frequently observed in various leukemias.
- Specific mechanisms of STAT dysregulation in leukemia are being elucidated.
Conclusions:
- Understanding STAT dysregulation in leukemia is crucial for developing targeted therapies.
- STAT signaling pathways represent promising targets for novel anti-leukemia treatments.
- Further research into STAT mechanisms may lead to improved therapeutic strategies for leukemia.
More Related Videos
Related Concept Videos
RNA Polymerase II Accessory Proteins
Eukaryotic Transcription Activators
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These domains are...
Master Transcription Regulators
Amplifying Signals via Enzymatic Cascade
MAPK Signaling Cascades
The JAK-STAT Signaling Pathway

